Table 5 FIB-4 index, APRI scores and SVR of patients
From: SVR Rates of HCV-infected population under PEG-IFN-α/R treatment in Northwest China
Genotype | No. of Patients (% of Total) | No. of Patients with FIB-4 > 3.25 (% of Total) | No. of Patients with APRI > 2 (% of Total) | Total SVR (%) | No. of Patients with FIB-4 > 3.25 and SVR (%) | No. of Patients with APRI > 2 and SVR (%) |
|---|---|---|---|---|---|---|
1b | 90 (81.1) | 32 (16.8) | 19 (10.0) | 58 (64.4) | 19 (31.0) | 11 (30.3) |
2a | 76 (85.4) | 21 (11.1) | 12 (6.3)* | 67 (88.1) | 11 (39.4) | 8 (50.2) |
Other | 24 (77.4) | 7 (3.7) | 8 (4.2) | 13 | ||
Total | 190 (82.3) | 60 (31.6) | 30 (20.5) | 138 (72.6) |